Sensus Healthcare undertakes no obligation to revise or update any forward-looking statements, except as required by law. All forward-looking statements are subject to risks and uncertainties as ...
A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.
Tonix is advancing TNX-801's development with FDA feedback, collaborations for large-scale manufacturing ... Tonix owns and operates a state-of-the art infectious disease research facility in ...